nitroglycerin and docetaxel anhydrous

nitroglycerin has been researched along with docetaxel anhydrous in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Asada, M; Fuji, H; Inoue, D; Kanda, A; Kaneta, T; Kondo, T; Nakayama, K; Okinaga, S; Sasaki, H; Sasaki, T; Suzuki, S; Suzuki, T; Takai, Y; Watanabe, M; Yamanda, S; Yamaya, M; Yanagihara, K; Yasuda, H; Yoshida, M; Zayasu, K	1
Bettaieb, A; Bouaouiche, S; Dondaine, L; Isambert, N; Jeannin, JF; Laurens, V; Magadoux, L; Plenchette, S; Reveneau, S	1

Reviews

1 review(s) available for nitroglycerin and docetaxel anhydrous

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for nitroglycerin and docetaxel anhydrous

Article	Year
Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Nov-15, Volume: 12, Issue:22 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Combined Modality Therapy; Disease Progression; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Male; Middle Aged; Nitroglycerin; ROC Curve; Taxoids; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A	2006

Article

Year

Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Nov-15, Volume: 12, Issue:22

Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Combined Modality Therapy; Disease Progression; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Male; Middle Aged; Nitroglycerin; ROC Curve; Taxoids; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A

2006

Other Studies

1 other study(ies) available for nitroglycerin and docetaxel anhydrous

Article	Year
Glyceryl trinitrate‑induced cytotoxicity of docetaxel‑resistant prostatic cancer cells is associated with differential regulation of clusterin. International journal of oncology, 2019, Volume: 54, Issue:4 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Clusterin; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Growth Differentiation Factor 15; Humans; Male; Nitroglycerin; Prostatic Neoplasms, Castration-Resistant; Xenograft Model Antitumor Assays; Zebrafish	2019

Article

Year

Glyceryl trinitrate‑induced cytotoxicity of docetaxel‑resistant prostatic cancer cells is associated with differential regulation of clusterin.

International journal of oncology, 2019, Volume: 54, Issue:4

Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Clusterin; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Growth Differentiation Factor 15; Humans; Male; Nitroglycerin; Prostatic Neoplasms, Castration-Resistant; Xenograft Model Antitumor Assays; Zebrafish

2019